VRC01 Pharmacokinetics at Mucosal Sites in HIV-infected and Healthy Adults

被引：0
|
作者：
Prabhakaran, Madhu S. P. [1 ]
Narpala, Sandeep R. [1 ]
Lin, Chien L. [1 ]
Bailer, Robert T. [1 ]
Shi, Wei [1 ]
Chen, Xuejun [1 ]
Kong, Wing-Pui [1 ]
Ledgerwood, Julie [1 ]
Koup, Richard A. [1 ]
McDermott, Adrian B. [1 ]
机构：
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OA08.04
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [41] Immunizations in HIV-infected adults
    Rivas, Pablo
    Dolores Herrero, Maria
    Puente, Sabino
    Ramirez-Olivencia, German
    Soriano, Vincent
    AIDS REVIEWS, 2007, 9 (03) : 173 - 187
  • [42] Vaccination in HIV-Infected Adults
    Crum-Cianflone, Nancy F.
    Wallace, Mark R.
    AIDS PATIENT CARE AND STDS, 2014, 28 (08) : 397 - 410
  • [43] HIV-specific broadly neutralizing monoclonal antibody, VRC01, minimally impacts time to viral rebound following treatment interruption in virologically suppressed, HIV-infected participants who initiated antiretroviral therapy during acute HIV infection
    Crowell, T. A.
    Colby, D. J.
    Pinyakorn, S.
    Intasan, J.
    Benjapornpong, K.
    Tanjnareel, K.
    Chomont, N.
    Trautmann, L.
    Tovanabutra, S.
    Krebs, S.
    Bolton, D.
    McDermott, A.
    Bailer, R.
    Doria-Rose, N.
    Patel, B.
    Gorelick, R. J.
    Fullmer, B. A.
    Visudhiphan, P.
    O'Connell, R. J.
    Tressler, R.
    Mascola, J.
    Michael, N. L.
    Robb, M. L.
    Phanuphak, N.
    Ananworanich, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 111 - 112
  • [44] Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults
    Durier, C
    Launay, O
    Meiffrédy, V
    Saïdi, Y
    Salmon, D
    Lévy, Y
    Guillet, JG
    Pialoux, G
    Aboulker, JP
    AIDS, 2006, 20 (07) : 1039 - 1049
  • [45] Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
    RM Lynch
    L Tran
    X Wu
    Y Li
    B Lee
    J Mascola
    Retrovirology, 9
  • [46] Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
    Lynch, R. M.
    Tran, L.
    Wu, X.
    Li, Y.
    Lee, B.
    Mascola, J.
    RETROVIROLOGY, 2012, 9
  • [47] Treatment of mucosal candidiasis in HIV-infected patients
    Zingman, BS
    JOURNAL DE MYCOLOGIE MEDICALE, 1996, 6 : 3 - 9
  • [48] Mucosal antibody responses in HIV-infected individuals
    Brewer, LR
    Prince, SJ
    Kulhavy, R
    Lu, A
    Jackson, S
    Goepfert, PA
    Mestecky, J
    FASEB JOURNAL, 2000, 14 (06): : A943 - A943
  • [49] Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01
    Andrianov, Alexander M.
    Kashyn, Ivan A.
    Tuzikov, Alexander V.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2015, 61 : 262 - 271
  • [50] In silico discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01
    Skolnick, Jeffrey
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 : 121 - 121
12345